uniQure (QURE) EBIT (2016 - 2026)
uniQure (QURE) recorded quarterly EBIT of -$45.7 million in Q1 2026, down 154.2% quarter-over-quarter from $84.3 million in Q4 2025, and down 16.24% on a YoY basis from -$54.6 million in Q1 2025.
uniQure (QURE) EBIT (2016 - 2026) Analysis & Trends
uniQure's EBIT history runs 11 years deep, the most recent figure standing at -$45.7 million for Q1 2026.
- In Q1 2026, EBIT fell 16.24% year-over-year to -$45.7 million; the TTM figure through Mar 2026 stood at -$56.3 million (up 66.78% YoY), while the FY2025 annual figure was -$49.9 million, up 72.93% from the prior year.
- EBIT was -$45.7 million for Q1 2026 at uniQure, down from $84.3 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $142.0 million in Q4 2023 to a low of -$81.9 million in Q3 2023.
- Historically, EBIT has averaged -$29.5 million across 5 years, with a median of -$45.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: EBIT surged 435.95% in 2023, then tumbled 132.27% in 2024.
- A 5-year view of EBIT shows it stood at $26.5 million in 2022, then soared by 435.95% to $142.0 million in 2023, then sank by 132.27% to -$45.8 million in 2024, then soared by 284.06% to $84.3 million in 2025, then plunged by 154.2% to -$45.7 million in 2026.
- The last three EBIT figures came in at -$45.7 million (Q1 2026), $84.3 million (Q4 2025), and -$51.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -45.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.72 Mn |
| Dec 31, 2025 | 84.35 Mn |
| Sep 30, 2025 | -51.04 Mn |
| Jun 30, 2025 | -43.87 Mn |
| Mar 31, 2025 | -39.33 Mn |
| Dec 31, 2024 | -45.83 Mn |
| Sep 30, 2024 | -40.23 Mn |
| Jun 30, 2024 | -44.01 Mn |
| Mar 31, 2024 | -54.23 Mn |
| Dec 31, 2023 | 142.03 Mn |
| Sep 30, 2023 | -81.88 Mn |
| Jun 30, 2023 | -65.07 Mn |
| Mar 31, 2023 | -74.17 Mn |
| Dec 31, 2022 | 26.50 Mn |
| Sep 30, 2022 | -59.52 Mn |
| Jun 30, 2022 | -56.06 Mn |
| Mar 31, 2022 | -54.08 Mn |
| Dec 31, 2021 | -225.35 Mn |
| Sep 30, 2021 | -45.00 Mn |
| Jun 30, 2021 | 398.01 Mn |